— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

venBio Partners LLC

Q4 2025 · Filed 2026-02-17
Market Value
$88M
+44.3%
Holdings
5
New Purchases
0
Added To
0
Closed
0
Reduced
2
Top 10 Concentration
100.0%
Turnover
0.0%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ALMS 51.51% 30.39% +21.12% $45M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ALXO 12.52% 29.27% -16.74% $11M
ARTV 3.18% 5.44% -2.26% $3M
HRMY 20.91% 22.23% -1.32% $18M
LYEL 11.87% 12.68% -0.80% $10M

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 1 $18M 20.9%
Small Cap 2 $48M 54.7%
Micro Cap 2 $21M 24.4%

Portfolio Analytics

Avg Market Cap
$773M
Median Market Cap
$334M
Avg P/E
12.7
Median P/E
12.7
Avg Dividend Yield
—%
Avg Beta
0.56
# Stocks
5
# ETFs / Funds
0

Top Holdings (5 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 ALMS 51.51% 4,619,803 $45M $9.76 $27M — —
2 HRMY 20.91% 489,194 $18M $37.42 $5M — —
3 ALXO 12.52% 9,699,925 $11M $1.13 -$7M — —
4 LYEL 11.87% 337,697 $10M $30.78 $3M -135,782 -28.7%
5 ARTV 3.18% 648,507 $3M $4.29 -$515K -500,468 -43.6%
View SEC EDGAR Filings for venBio Partners LLC →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms